![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 3, 2056-2068, January 19, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1




From the
Division of Biology, MC 156-29, California Institute of Technology, Pasadena, California 91125, the
Department of Biochemistry, Seoul National University, Seoul, Korea, the ¶Department of Biology, College of Sciences, Kyung Hee University, Seoul 130-701, Korea, the ||Department of Neurology, Brain Research Institute, The David Geffen School of Medicine, UCLA, Los Angeles, California 90095, and **Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129
Many inhibitor of apoptosis (IAP) family proteins inhibit apoptosis. IAPs contain N-terminal baculovirus IAP repeat domains and a C-terminal RING ubiquitin ligase domain. Drosophila IAP DIAP1 is essential for the survival of many cells, protecting them from apoptosis by inhibiting active caspases. Apoptosis initiates when proteins such as Reaper, Hid, and Grim bind a surface groove in DIAP1 baculovirus IAP repeat domains via an N-terminal IAP-binding motif. This evolutionarily conserved interaction disrupts DIAP1-caspase interactions, unleashing apoptosis-inducing caspase activity. A second Drosophila IAP, DIAP2, also binds Rpr and Hid and inhibits apoptosis in multiple contexts when overexpressed. However, due to a lack of mutants, little is known about the normal functions of DIAP2. We report the generation of diap2 null mutants. These flies are viable and show no defects in developmental or stress-induced apoptosis. Instead, DIAP2 is required for the innate immune response to Gram-negative bacterial infection. DIAP2 promotes cytoplasmic cleavage and nuclear translocation of the NF-
B homolog Relish, and this requires the DIAP2 RING domain. Increasing the genetic dose of diap2 results in an increased immune response, whereas expression of Rpr or Hid results in down-regulation of DIAP2 protein levels. Together these observations suggest that DIAP2 can regulate immune signaling in a dose-dependent manner, and this can be regulated by IBM-containing proteins. Therefore, diap2 may identify a point of convergence between apoptosis and immune signaling pathways.
Received for publication, August 22, 2006
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1-4.
1 To whom correspondence should be addressed: Division of Biology, MC 156-29, California Institute of Technology, 1200 East California Blvd., Pasadena, CA 91125. Tel.: 626-395-3399; Fax: 626-449-0756; E-mail: haybruce{at}caltech.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. S. Ribeiro, E. Kuranaga, T. Tenev, F. Leulier, M. Miura, and P. Meier DIAP2 functions as a mechanism-based regulator of drICE that contributes to the caspase activity threshold in living cells J. Cell Biol., December 31, 2007; 179(7): 1467 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Rawls, S. A. Schultz, R. D. Mitra, and T. Wolff Bedraggled, a Putative Transporter, Influences the Tissue Polarity Complex During the R3/R4 Fate Decision in the Drosophila Eye Genetics, September 1, 2007; 177(1): 313 - 328. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |